Rabat – Artificial intelligence is often hailed as a revolution in healthcare, promising faster diagnoses and smarter, more personalized care. Yet, as the research of Dr. Ahmed Zahlan, a recent PhD ...

President Donald Trump's almost $1 trillion in cuts to Medicaid and CHIP could have a "widespread impact" on children, Ye Shen told Newsweek.

Robotics startup CynLr has teamed up with neuroscientists at IISc’s Vision Lab to build intuitive robots that could transform automation. Tie-up will also fund PhDs and train new talent.

With AI moving at a fast pace, oculomics — the study of the eye as a window to systemic health — is expanding its potential and gaining increasing attention. The past few years have seen an abundance ...

The 2025 EAT-Lancet Report suggests that eating mainly plants — with only a small amount of meat and dairy — could be one of the simplest ways to combat climate change. Known as the Planetary Health ...

Micah Card and Emanuel Suarez Jimenez were awarded the 2025 Spencer Dissertation Fellowships to study crucial emerging issues in education.

Other depictions in the speculative art pieces include a Bristol protest in 2057 to “bring back bricks”, the possibility of growing our own home the way we grow plants by 2100 and engineered upgrades ...

Combined testing uptake (HCV RDT or HCV RDT/RNA) was higher for the community-based strategy than for the facility-based strategy. The involvement of community health workers improved first contact ...

Troy University’s fall enrollment data is in and the numbers add up to a slight overall increase.  Sohail Agbotwala, Troy’s Vice Chancellor for Students Services and Administrations, said the overall ...

Around 25% of people with cancer in the U.S. are active smokers when they are diagnosed, and studies have found that many of them continue to smoke during treatment.

Ohio State University begins a $19.5 million NIH-funded study called ARTEMIS to improve suicide risk detection.

Structure Therapeutics Inc. is a clinical-stage biotech focused on oral GLP-1 drugs for obesity, targeting a rapidly growing sector in pharma market. Learn more about GPCR stock here.